Psychiatry & Neurology Doctors in San Mateo, CA Accepting Medicare

84 Psychiatry & Neurology doctors found. Showing 81 - 84

Paul I Wachter, M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 327 N San Mateo Dr, Ste 7, San Mateo, CA 94401 Phone: 650-347-9146    Fax: 650-343-3078

Dr. Kapil Chopra, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2000 Alameda De Las Pulgas Ste 235, San Mateo, CA 94403 Phone: 650-385-9821

Graham Beaumont, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4100 S El Camino Real, San Mateo, CA 94403 Phone: 650-349-6121    Fax: 650-349-7077

Dr. Gregory John Tarasoff, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2600 S El Camino Real, San Mateo, CA 94403 Phone: 650-373-0777

News Archive

Purdue researchers find potential way to overcome limitations posed by CAR T-cell therapy

Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

PreventiveLabs.com offers on-line blood test kit

In the wake of therecent death of McDonald's Chairman and CEO James Cantalup, it appears thatmore and more people are realizing the importance of taking preventivemeasures to detect health problems before the normal symptoms occur.

FDA approves APP's preservative-free Methotrexate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.

FDA takes important steps regarding genetically engineered plants and animals intended for food

Based on sound science and a comprehensive review, the U.S. Food and Drug Administration is taking several important steps today regarding food from genetically engineered (GE) plants and animals, including the first approval for a genetically engineered animal intended for food, AquAdvantage Salmon.

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3
• 4
• 5(current)